Covering pathophysiology, treatment goals, methotrexate’s mechanism of action, oral versus subcutaneous formulations, safety monitoring, counselling points, and shared decision-making strategies, the course empowers pharmacists to enhance patient outcomes and collaborate confidently with prescribers in chronic inflammatory disease management.